Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 |
filingDate |
2008-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af54ce655cb8ed48c6bc2d9eef42bfe3 |
publicationDate |
2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010144679-A1 |
titleOfInvention |
Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture |
abstract |
The present invention provides a multi-component kit comprising a therapeutically effective amount of a bisphosphonate or analogue thereof in combination with an effective amount of Vitamin D, a metabolite thereof, a precursor thereof or an analogue thereof, wherein the kit provides instructions for daily dosing and correct chronological order of administration of components to provide a dosing regime for reducing secondary osteoporotic skeletal fractures in subjects at risk for vitamin D deficiency. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9949992-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11738033-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11173168-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11154509-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11007204-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9867838-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020101089-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11007205-B2 |
priorityDate |
2007-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |